Skip to content

Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.

Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.

A patient worried that cancer may run in her family finds answers through genetic testing offering by Stanford Medicine's Humanwide project.

A patient worried that cancer may run in her family finds answers through genetic testing offering by Stanford Medicine's Humanwide project.

A recent Stanford Medicine event, Celebrating Cancer Survivors, brought survivors together to share a variety of stories about living with cancer.

A recent Stanford Medicine event, Celebrating Cancer Survivors, brought survivors together to share a variety of stories about living with cancer.

Stanford researchers find that colorectal cancer is being diagnosed at later stages in younger patients, suggesting risk of the disease is growing.

Stanford researchers find that colorectal cancer is being diagnosed at later stages in younger patients, suggesting risk of the disease is growing.

A radio show features a Stanford oncologist discussing ultra-fast "flash" radiation therapy, which may kill cancer cells with less collateral damage.

A radio show features a Stanford oncologist discussing ultra-fast "flash" radiation therapy, which may kill cancer cells with less collateral damage.

Editors note: The family has requested removing the video to protect their daughter's privacy. We apologize for the inconvenience.

Editors note: The family has requested removing the video to protect their daughter's privacy. We apologize for the inconvenience.

Molecular data identifies breast cancer subgroups likely to recur decades after successful treatment, predicts probable timing and location of metastases.

Molecular data identifies breast cancer subgroups likely to recur decades after successful treatment, predicts probable timing and location of metastases.

Cru Silva was diagnosed with a type of eye cancer when he was 18 months old. After nearly a year of treatments, he's healthy and back home in Hawaii.

Cru Silva was diagnosed with a type of eye cancer when he was 18 months old. After nearly a year of treatments, he's healthy and back home in Hawaii.

Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.

Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.

Published on

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Published on